Sheng Chang Pharmaceutical   Report issue

For profit Phase 1
Founded: Zhongli Taiwan (1946)
Status: Left NME R&D (2010)

Organization Overview

First Clinical Trial
2000
NCT00155675
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

gusuibu (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoporosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1